• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Researchers develop method for storing vaccines at room temp

November 30, 2016 By Sarah Faulkner

Researchers develop method for storing vaccines at room tempResearchers at Ecole Polytechnique Federale de Lausanne‘s Supramolecular Nanomaterials and Interfaces Laboratory claim they have developed methods for 3 vaccine additives to help store vaccines at room temperature. The team’s work was published in Nature Communications. 

The need to keep vaccines within a temperature range of 2-8°C contributes to low immunization-coverage rates, because shipping vaccines in an unbroken temperature-controlled supply chain is a logistical and costly endeavor in remote areas. But this team of researchers say they have devised a way to use small quantities of nanoparticles, FDA-approved polymer, or higher amounts of sucrose to stabilize the medicines at room temperature for long periods of time.

Viral-vector vaccines, the most common kind, normally last for a few days at room temperature before the viral components of the vaccine loses its structural integrity. “These components fluctuate by their very nature,” head of SUNMIL Francesco Stellacci said in prepared remarks. “They are combined in a stable form, and the low temperature maintains that balance. But the thermally induced fluctuations eventually lead to a loss of integrity of the viral vector.”

The team found that negatively charged nanoparticles could apply osmotic pressure on the inactivated viruses, countering the outward osmotic pressure built up within the virus from its genetic material. The counter-osmotic pressure keeps the virus intact.

The 2nd additive, polymers, were added to the virus’s capsid. The capsid, which envelops the inactivated virus, stiffens and slows the virus’s oscillations.

Finally, the team added sucrose to the vaccine, making the environment more viscous and slowing down fluctuations. “It’s a little like adding honey, where all motion is slowed down,” Stellacci said.

The researchers tested their methods on a vaccine in development for a tropical virus known as Chikungunya. Using their techniques, they were able to stabilize the vaccine for 10 days and then successfully inoculate mice with it. “The next step will be to run more extensive tests on specific vaccines, possibly combining the three different approaches,” Stellacci said.

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: Ecole Polytechnique Federale de Lausanne

IN CASE YOU MISSED IT

  • MiniMed claims quick FDA clearance for Fit patch pump
  • Tandem’s Mobi pump wins FDA clearance for 7-day tubeless wearable set
  • Senseonics delivers ‘breakout quarter’ more than doubling Eversense 365 revenue
  • Tandem Diabetes Care names successor as CEO Sheridan retires
  • MiniMed names new CMO ahead of planned retirement

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS